- Home
- SION vs RXST Comparison
SION vs RXST Comparison
Compare SION & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- RXST
- Stock Information
- Founded
- SION 2019
- RXST 1997
- Country
- SION United States
- RXST United States
- Employees
- SION N/A
- RXST N/A
- Industry
- SION
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SION
- RXST Health Care
- Exchange
- SION NYSE
- RXST Nasdaq
- Market Cap
- SION 564.4M
- RXST 631.1M
- IPO Year
- SION 2025
- RXST 2021
- Fundamental
- Price
- SION $14.49
- RXST $13.61
- Analyst Decision
- SION Strong Buy
- RXST Buy
- Analyst Count
- SION 1
- RXST 10
- Target Price
- SION $32.00
- RXST $39.30
- AVG Volume (30 Days)
- SION 124.0K
- RXST 645.1K
- Earning Date
- SION 05-12-2025
- RXST 08-04-2025
- Dividend Yield
- SION N/A
- RXST N/A
- EPS Growth
- SION N/A
- RXST N/A
- EPS
- SION N/A
- RXST N/A
- Revenue
- SION N/A
- RXST $148,310,000.00
- Revenue This Year
- SION N/A
- RXST $22.16
- Revenue Next Year
- SION N/A
- RXST $20.91
- P/E Ratio
- SION N/A
- RXST N/A
- Revenue Growth
- SION N/A
- RXST 46.70
- 52 Week Low
- SION $7.26
- RXST $12.53
- 52 Week High
- SION $25.19
- RXST $60.81
- Technical
- Relative Strength Index (RSI)
- SION N/A
- RXST 38.20
- Support Level
- SION N/A
- RXST $13.41
- Resistance Level
- SION N/A
- RXST $14.88
- Average True Range (ATR)
- SION 0.00
- RXST 0.73
- MACD
- SION 0.00
- RXST -0.14
- Stochastic Oscillator
- SION 0.00
- RXST 6.78
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.